Adalimumab and its Impurities

Adalimumab is a biologic medication classified as a TNF (tumor necrosis factor) inhibitor. It is a recombinant human monoclonal antibody that targets and neutralizes TNF-alpha, a protein involved in systemic inflammation. It is administered via subcutaneous injection and is used to treat a variety of autoimmune and inflammatory conditions. Reference standards of Adalimumab API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.